Description: This article attempts to make a modest contribution to the dialogue on the potential and risks associated with novel treatments such as cell & gene therapies. With a fast-expanding roster of what are believed to be one-time treatments at ever increasing price points aimed at curing a wider swatch of the population, they are as much a source of relief for patients stuck in medical limbo, as they are a source of anxiety for payers.

Description: Panelists at this session of the SOA 1997 Palm Desert Spring Meeting discuss medical excess coverage which is provided to hospitals and/or physician groups to reimburse such groups for benefits in excess of a deductible. This coverage typically involves situations where providers are taking capitation.